Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Eyegate Pharmaceuticals Inc. EYEGV

Healthcare Biotechnology

Recent & Breaking News (GREY:EYEGV)

EyeGate Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update

GlobeNewswire August 7, 2017

EyeGate Pharma Enrolls First Patient in Phase 2b Clinical Study of EGP-437 for Cataract Surgery

GlobeNewswire August 1, 2017

EyeGate Announces Completion of $10.0 Million Public Offering

GlobeNewswire June 14, 2017

15 Biggest Mid-Day Losers For Friday

Benzinga.com  June 9, 2017

A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Wholesale Inventories Report

Benzinga.com  June 9, 2017

EyeGate Announces $10.0 Million Public Offering

GlobeNewswire June 9, 2017

EyeGate Receives Milestone Payment from Valeant Pharmaceuticals for EGP-437 for post-operative ocular inflammation and pain in ocular surgery patients

GlobeNewswire May 22, 2017

Biotech Stocks on Investors' Radar -- BioMarin Pharma, Eyegate Pharma, Navidea Biopharma, and Cellectar Biosciences

PR Newswire May 9, 2017

EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update

GlobeNewswire May 8, 2017

EyeGate Submits Investigational Device Exemption (IDE) Filing for Second Pilot Study of Ocular Bandage Gel

GlobeNewswire May 4, 2017

Research Reports Initiation on Biotech Stocks -- Sangamo, Eyegate Pharma, Synthetic Biologics, and Regulus

PR Newswire March 23, 2017

EyeGate Pharma Strengthens Scientific Advisory Board with Appointments of Daniel S. Durrie, M.D. and Randall J. Olson, M.D.

GlobeNewswire March 13, 2017

18 Biggest Mid-Day Losers For Friday

Benzinga.com  February 24, 2017

EyeGate Pharmaceuticals Reports Full-year 2016 Financial Results and Provides Business Update

GlobeNewswire February 23, 2017

Exclusive: Clinical-Stage Specialty Pharma EyeGate CEO On Relationship With Valeant

Benzinga.com  February 23, 2017

18 Biggest Mid-Day Losers For Wednesday

Benzinga.com  February 22, 2017

Mid-Afternoon Market Update: Dow Surges Over 100 Points; Eyegate Pharmaceuticals Shares Spike Higher

Benzinga.com  February 21, 2017

18 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  February 21, 2017

Mid-Morning Market Update: Markets Open Higher; Wal-Mart Earnings Beat Views

Benzinga.com  February 21, 2017

20 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  February 21, 2017